|
DGAP Voting Rights Announcement: STADA Arzneimittel AG
STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
22.10.2018 / 14:41
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
|
2. Reason for notification
| |
Acquisition/disposal of shares with voting rights |
| |
Acquisition/disposal of instruments |
| |
Change of breakdown of voting rights |
| X |
Other reason:
Lapse of financial instruments due to the tendering of shares into the delisting tender offer by certain shareholders pursuant to irrevocable undertaking |
3. Details of person subject to the notification obligation
| Name: |
City and country of registered office: |
| Bain Capital Investors, LLC |
Wilmington, Delaware
United States of America (USA) |
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
| |
% of voting rights attached to shares
(total of 7.a.) |
% of voting rights through instruments
(total of 7.b.1 + 7.b.2) |
total of both in %
(7.a. + 7.b.) |
total number of voting rights of issuer |
| Resulting situation |
65.31 % |
7.08 % |
72.39 % |
62,342,440 |
| Previous notification |
65.31 % |
12.06 % |
77.38 % |
/ |
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
| ISIN |
absolute |
in % |
| |
direct
(Sec. 33 WpHG) |
indirect
(Sec. 34 WpHG) |
direct
(Sec. 33 WpHG) |
indirect
(Sec. 34 WpHG) |
| DE0007251803 |
|
40,716,644 |
% |
65.31 % |
| Total |
40,716,644 |
65.31 % |
b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
| Tender under domination and profit and loss transfer agreement |
n/a |
n/a |
491 |
0.0008 % |
| |
|
Total |
491 |
0.0008 % |
b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
| Irrevocable/ purchase option |
n/a |
n/a |
Physical |
4,414,823 |
7.08 % |
| |
|
|
Total |
4,414,823 |
7.08 % |
8. Information in relation to the person subject to the notification obligation| |
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). |
| X |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name |
% of voting rights (if at least held 3% or more) |
% of voting rights through instruments (if at least held 5% or more) |
Total of both (if at least held 5% or more) |
| Bain Capital Investors, LLC |
% |
% |
% |
| Bain Capital Partners Europe IV, L.P. |
% |
% |
% |
| Bain Capital Europe Fund IV, L.P. |
% |
% |
% |
| Universe Luxembourg S.C.A. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding GmbH |
% |
% |
% |
| Nidda Healthcare GmbH |
65.31 % |
7.08 % |
72.39 % |
| |
|
|
|
| Bain Capital Investors, LLC |
% |
% |
% |
| Bain Capital Partners Europe IV, L.P. |
% |
% |
% |
| Bain Capital Europe Fund IV, L.P. |
% |
% |
% |
| Universe Luxembourg GP S.à r.l. |
% |
% |
% |
| Universe Luxembourg S.C.A. |
% |
% |
% |
| Nidda Topco S.à r.l |
% |
% |
% |
| Nidda Midco S.à r.l |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding GmbH |
% |
% |
% |
| Nidda Healthcare GmbH |
65.31 % |
7.08 % |
72.39 % |
| |
|
|
|
| Bain Capital Investors, LLC |
% |
% |
% |
| Bain Capital Partners XI, L.P. |
% |
% |
% |
| Bain Capital Fund XI, L.P. |
% |
% |
% |
| Universe Luxembourg S.C.A. |
% |
% |
% |
| Nidda Topco S.à r.l. |
% |
% |
% |
| Nidda Midco S.à r.l |
% |
% |
% |
| Nidda German Topco GmbH |
% |
% |
% |
| Nidda German Midco GmbH |
% |
% |
% |
| Nidda BondCo GmbH |
% |
% |
% |
| Nidda Healthcare Holding GmbH |
% |
% |
% |
| Nidda Healthcare GmbH |
65.31 % |
7.08 % |
72.39 % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG| Date of general meeting: |
|
| Holding position after general meeting: |
% (equals voting rights) |
10. Other explanatory remarks:
22.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
Der finanzen.at Ratgeber für Aktien!
ETF-Sparplan